Drug Type Small molecule drug |
Synonyms Isovaleramide (USAN), NPS-1776 |
Target |
Action inhibitors |
Mechanism ADHs inhibitors(Alcohol dehydrogenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC5H11NO |
InChIKeySANOUVWGPVYVAV-UHFFFAOYSA-N |
CAS Registry541-46-8 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D04637 | Isovaleramide | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Migraine Disorders | Phase 2 | United States | 31 Dec 2003 | |
| Acute Kidney Injury | Preclinical | China | 26 Sep 2024 |





